Paradoxical disease flare, skin infection and hypogammaglobulinaemia in patients with pemphigus vulgaris treated with rituximab
Clinical and Experimental Dermatology · 2024
DOI: 10.1093/ced/llad347 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Jignaben K Padhiyar und 6 weiteren Autor:innen. Beteiligte Einrichtung: GCS Medical College Hospital and Research Centre, Ahmedabad, Gujarat, India. Hauptthemen laut MEDLINE: Pemphigus, Agammaglobulinemia, Skin Diseases, Infectious. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Patients with pemphigus vulgaris can develop hypogammaglobulinaemia after an infusion of rituximab, which manifests clinically as a paradoxical disease flare accompanying skin lesion infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- GCS Medical College Hospital and Research Centre, Ahmedabad, Gujarat, India.
ORCID-Profile: Nayan H Patel, Jahnvi R Patel
Zitieren
APA
Padhiyar, J. K., Patel, N. H., Lakum, M. P., Patel, J. R., Patel, K. A., Patel, H. B., & Chaudhary, P. B. (2024). Paradoxical disease flare, skin infection and hypogammaglobulinaemia in patients with pemphigus vulgaris treated with rituximab. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad347
Vancouver
Padhiyar JK, Patel NH, Lakum MP, Patel JR, Patel KA, Patel HB, et al. Paradoxical disease flare, skin infection and hypogammaglobulinaemia in patients with pemphigus vulgaris treated with rituximab. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llad347
BibTeX
@article{Padhiyar2024,
author = {Padhiyar, Jignaben K and Patel, Nayan H and Lakum, Megha P and Patel, Jahnvi R and Patel, Kathak A and Patel, Harisiddhi B and Chaudhary, Prashant B},
title = {Paradoxical disease flare, skin infection and hypogammaglobulinaemia in patients with pemphigus vulgaris treated with rituximab},
journal = {Clinical and Experimental Dermatology},
year = {2024},
doi = {10.1093/ced/llad347}
}
EUVIMED